[The retrospective analysis of prophylactic administration of pegylated recombinant human granulocyte colony stimulating factor in lymphoma patients undergoing chemotherapy]

Zhonghua Xue Ye Xue Za Zhi. 2014 May;35(5):453-5. doi: 10.3760/cma.j.issn.0253-2727.2014.05.017.

[Article in Chinese]

Authors

Qunling Zhang¹, Xiaojian Liu¹, Weina Shen¹, Jiachen Wang¹, Xiaonan Hong¹, Ye Guo¹

Affiliation

¹ Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai 200032, China.

PMID: 24857220
DOI: 10.3760/cma.j.issn.0253-2727.2014.05.017

No abstract available

MeSH terms

Granulocyte Colony-Stimulating Factor / therapeutic use*
Humans
Lymphoma / drug therapy*
Recombinant Proteins / therapeutic use
Retrospective Studies

Substances

Recombinant Proteins
Granulocyte Colony-Stimulating Factor